Other authors also described that H2AFX low expression compromise the apoptotic response to IM and promote blast crisis of CML, as well as the H2AFX deficiency, promotes B-cell tumorigenesis, suggesting that deregulation could make cells more sensitive to leukemogenic factors [64]. This evidence concerns the gene H2AX and chronic myelogenous leukemia, BCR-ABL1 positive.